SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?


To: Kirk © who wrote (12444)11/19/2019 4:13:45 PM
From: HardToFind  Read Replies (1) | Respond to of 12873
 
Yes, it's awfully convenient for Diwan to continue spending NNVC money on IP assets for TheraCour (& Diwan) as NNVC edges into insolvency and bankruptcy. I'm sure the board will say these actions were in the best interest of NNVC shareholders.

The lab is presumably worth ~$5 Mn (to the right buyer)...like TheraCour?